|
gptkbp:instanceOf
|
gptkb:chemical_compound
vitamin D metabolite
|
|
gptkbp:ATCCode
|
A11CC06
|
|
gptkbp:availableOn
|
gptkb:drug
dietary supplement
|
|
gptkbp:brand
|
Calcidiol
Calcifediol
Calderol
Dedrogyl
Hidroferol
|
|
gptkbp:CASNumber
|
19356-17-3
|
|
gptkbp:chemicalFormula
|
C27H44O2
|
|
gptkbp:eliminationHalfLife
|
15-25 days
|
|
gptkbp:furtherMetabolizedIn
|
gptkb:kidney
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
calcifediol
|
|
gptkbp:isMeasuredAs
|
marker of vitamin D status in blood
|
|
gptkbp:isVitaminD2OrD3
|
gptkb:vitamin_A
|
|
gptkbp:IUPACName
|
(3β,5Z,7E,22E)-9,10-secocholesta-5,7,10(19),22-tetraen-3-ol
|
|
gptkbp:KEGGID
|
D01779
|
|
gptkbp:MeSH_ID
|
D017400
|
|
gptkbp:metabolism
|
gptkb:cholecalciferol
liver
|
|
gptkbp:molecularWeight
|
400.64 g/mol
|
|
gptkbp:predecessor
|
gptkb:calcitriol
|
|
gptkbp:producedBy
|
hydroxylation of cholecalciferol in the liver
|
|
gptkbp:PubChem_CID
|
CHEMBL1201207
5280453
DB11772
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
|
|
gptkbp:sideEffect
|
gptkb:hypercalcemia
hypercalciuria
|
|
gptkbp:synonym
|
gptkb:25-hydroxyvitamin_D3
25-hydroxycholecalciferol
|
|
gptkbp:UNII
|
1C6V77QF41
|
|
gptkbp:usedFor
|
treatment of osteoporosis
treatment of vitamin D deficiency
treatment of hypoparathyroidism
|
|
gptkbp:bfsParent
|
gptkb:vitamin_A
|
|
gptkbp:bfsLayer
|
4
|